[PDF] Top 20 Current progress in stem cell therapy for type 1 diabetes mellitus

... islet-like cell clusters ...distinct cell popula- tion within islets isolated from the human pancreas that express nestin, termed nestin-positive islet-derived pro- genitor cells ...of stem cells and ... See full document

... Of the 23 patients included, 20 remained free from insu- lin for some period. Of these, 12 have been continuously insulin-free since treatment, 8 became transiently insulin- free and 3 maintained daily insulin doses. In ... See full document

... Background: Stem cell transplantation is an emerging therapeutic option for type 1 diabetes ...of stem cell treatment for T1D by ...keywords: stem cell; ... See full document

... as diabetes mellitus ...of stem cells, the use of stem cells to improve diabetic patientswas remarkable as a novel alternative method ...Indeed, stem cell therapy can ... See full document

... Methods/Design: Therefore, we composed a trial consisting of two cohorts with two therapeutic options within each cohort (conventional versus intensive therapy) and a three-year follow-up. In one group the ... See full document

... Our current knowledge of T1D etiopathogenesis has been signi fi cantly improved by GWAS and recent epigenome-wide associa- tion study analyses aimed at identifying epigenetic mechanisms with the po- tential to ... See full document

... combination therapy with mitiglinide and voglibose on postprandial hyperglycemia and vascular endothelial function in T2DM ...such therapy is considered to be suitable for achieving strict postprandial ... See full document

... unable to determine rates of hypoglycemia accurately. This study relates our experience with the initiation of treatment with insulin glargine at the time of diagnosis for children with T1DM. Although we report our ... See full document

... insulin-resistant cell models, as evidenced by restored insulin and stimulated glucose uptake, via up-regulation of the GLUT4 gene and reductions in IL-6 and plasminogen activator inhibi- tor-1 ... See full document

... Th17 cell responses, with complete abrogation of new clinical ...nosed type 1 diabetes mellitus sign a predominant Th1- driven autoimmune process, suggesting that a Th1 im- mune ... See full document

... eliminate current obstacles to insulin therapy observed in South Africa by educating patients on signs and symptoms of hypoglycaemia and by optimising healthcare resources such that good glycaemic control ... See full document

... DR (microaneurysms only); moderate nonproliferative DR (more than just microaneurysms but less than severe non- proliferative DR); severe nonproliferative DR (more than 20 intraretinal hemorrhages in each of four ... See full document

... pramlintide therapy include hypoglycemia, nausea, subcutaneous route of administration, and the use and expense of another ...of therapy (Ratner et al 2002; Hollander et al 2003b) The manu- facturer ... See full document

... Potential mechanisms that underlying this positive association remains unclear. However, several mecha- nisms might involve in these associations. Firstly, acti- vated platelets could express soluble CD40 ligand (CD40L) ... See full document

... of therapy (transition period and on-going therapy) and at various environments (home, work, college), which should be addressed by health care providers and policy ...the current insulin pump ... See full document

... beta cell lesion, the more antigens are expressed, which will reactivate the ...beta cell destruction would no longer allow a proper insulin secre- tion, resulting in the expression of ... See full document

... their diabetes consultation, patients were approached and selected by trained clinical psy- chologists taking into account the inclusion ...level, diabetes type, therapy and antidepressant ... See full document

... Following the working definitions of appropriate, potentially inappropriate, and inappropriate prescription (see Appro- priateness of LLT prescription, in the Patients and methods section), 71.5% of the study subjects ... See full document

... keywords type 1 diabetes mellitus, pramlintide, metformin, glucagon-like peptide-1 receptor agonist, exenatide, lira- glutide, dulaglutide, albiglutide, lixisenatide, semaglutide, ... See full document

... their diabetes management day to day without professionals immediately at ...some diabetes problems that patients ...their diabetes is their ... See full document